Jun-Jie Yin, Ph.D., CFSAN For outstanding work in the development of electron spin resonance (ESR) techniques to understand the formation of free radicals in nanomaterials, cosmetics and dietary supplements.

2012Mikhail Ovanesov, Ph.D., CBERFor laboratory investigation that identified the cause of thromboembolic events in patients receiving immunoglobulin treatments, which led to immediate product withdrawal from the market.

Sue-Jane Wang, Ph.D., CDERFor a sustained record of published regulatory research in statistical design and methodology advancing complex and emerging clinical trial designs and analysis that support regulatory guidance, policies and review.

2009

Keith Peden, PhD, CBERFor the development of assays for the estimation of the risk posed by residual DNA in vaccines manufactured in neoplastic cell substrates.